BernagieC, DanckaertsM, WampersM, De HertM: Aripiprazole and acute extrapyramidal symptoms in children and adolescents: A meta-analysis. CNS Drugs, 30:807–818, 2016.
2.
GreenawayM, ElbeD: Focus on aripiprazole: A review of its use in child and adolescent psychiatry. J Can Acad Child Adolesc Psychiatry, 18:250–260, 2009.
3.
YoungMC, ShahN, CantrellFL, ClarkRF: Risk assessment of isolated aripiprazole exposures and toxicities: A retrospective study. Clin Toxicol (Phila), 47:580–583, 2009.
4.
StahlSM: Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications (4th ed.). Cambridge: Cambridge University Press, 2013.
5.
European Medicines Agency: Summary of product characteristics. Abilify: European Public Assessment Report. 2009. Available at www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Acute EPS in Minors Using Aripiprazole 815 Information/human/000471/WC500020170.pdf Accessed July20, 2020.
